SyntheticMR delivered sales growth of 63% Q1 but 13% below consensus expectations. Opex was in line with expectations of SEK -2.0m (cons SEK 0.7m). The company reiterates its 2023 guidance of sales of SEK >90m and EBIT margin of >20%. We expect mid single digit negative revisions to consensus 2023 sales expectations.

Länk till analysen